These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Inverse relation between estrogen receptors and cyclic adenosine 3':5'-monophosphate-binding proteins in hormone-dependent mammary tumor regression due to dibutyryl cyclic adenosine 3':5'-monophosphate treatment or ovariectomy. Bodwin JS; Clair T; Cho-Chung YS Cancer Res; 1978 Oct; 38(10):3410-3. PubMed ID: 210938 [TBL] [Abstract][Full Text] [Related]
3. Cyclic adenosine 3',5'-monophosphate-binding protein: role in ovariectomy-induced regression of a hormone-dependent mammary tumor in Sprague-Dawley female rats. Cho-Chung YS; Bodwin JS; Clair T J Natl Cancer Inst; 1978 May; 60(5):1175-8. PubMed ID: 205664 [TBL] [Abstract][Full Text] [Related]
4. Regression of hormone-dependent mammary tumors in Sprague-Dawley rats as a result of tamoxifen or pharmacologic doses of 17 beta-estradiol: cyclic adenosine 3',5'-monophosphate-mediated events. Bodwin JS; Hirayama PH; Rego JA; Cho-Chung YS J Natl Cancer Inst; 1981 Feb; 66(2):321-6. PubMed ID: 6256577 [TBL] [Abstract][Full Text] [Related]
5. Regulation of cyclic adenosine 3',5'-monophosphate in relation to growth of dimethylbenz[a]anthracene-induced mammary tumors in rats. Ip C; Dao TL Cancer Lett; 1980 Jan; 8(3):227-33. PubMed ID: 6261941 [TBL] [Abstract][Full Text] [Related]
6. Cyclic adenosine 3':5'-monophosphate and protein kinase activity in insulin-dependent and -independent mammary tumors. Shafie SM; Cho-Chung YS; Gullino PM Cancer Res; 1979 Jul; 39(7 Pt 1):2501-4. PubMed ID: 221106 [TBL] [Abstract][Full Text] [Related]
7. Sequential alterations in the hepatic content and metabolism of cyclic AMP and cyclic GMP induced by DL-ethionine: evidence for malignant transformation of liver with a sustained increase in cyclic AMP. DeRubertis FR; Craven PA Metabolism; 1976 Dec; 25(12):1611-25. PubMed ID: 186692 [TBL] [Abstract][Full Text] [Related]
8. Relationship of adenosine 3',5'-cyclic monophosphate and guanosine 3',5'-cyclic monophosphate to growth of dimethylbenz(a)anthracene-induced mammary tumors in rats. Matusik RJ; Hilf R J Natl Cancer Inst; 1976 Mar; 56(3):659-61. PubMed ID: 176403 [TBL] [Abstract][Full Text] [Related]
9. [Participation of the adenyl cyclase system in estradiol-activated growth of tumors in rat mammary glands]. Nagibneva IN; Morozova TM; Merkulova TI; Protopopova MV Biokhimiia; 1985 Feb; 50(2):231-6. PubMed ID: 2985126 [TBL] [Abstract][Full Text] [Related]
10. Antagonistic action between cyclic AMP and estrogen in phosphorylation of mammary tumor nuclear proteins. Cho-chung YS; Doud FJ Cancer Lett; 1978 Oct; 5(4):219-24. PubMed ID: 210929 [TBL] [Abstract][Full Text] [Related]
11. Concurrent changes in growth-related biochemical parameters during regression of hormone-dependent rat mammary tumors. Foecking MK; Abou-Issa H; Webb TE; Minton JP J Natl Cancer Inst; 1983 Oct; 71(4):773-8. PubMed ID: 6312151 [TBL] [Abstract][Full Text] [Related]
13. Cyclic AMP-binding protein and estrogen receptor: antagonism during nuclear translocation in a hormone-dependent mammary tumor. Bodwin JS; Hirayama PH; Cho-Chung YS Biochem Biophys Res Commun; 1981 Dec; 103(4):1349-55. PubMed ID: 6277332 [No Abstract] [Full Text] [Related]
14. The biochemical mechanisms of the stimulating action of estradiol on the growth of mammary tumours. Morozova TM; Mitina RL; Nagibneva IN; Ozhogina ZB; Salganik RI Exp Clin Endocrinol; 1986 Dec; 88(3):293-302. PubMed ID: 3030784 [TBL] [Abstract][Full Text] [Related]
15. Levels of cyclic nucleotides in autotransplanted 7, 12-dimethylbenz[a]anthracene-induced rat mammary tumors during their growth and regression. Lee C J Natl Cancer Inst; 1980 Nov; 65(5):1029-32. PubMed ID: 6253705 [TBL] [Abstract][Full Text] [Related]
16. Growth inhibition and the regulation of cyclic AMP by the triphenylethylene anti-estrogen tamoxifen in the quail oviduct. Fanidi A; Pageaux JF; Courion C; Fayard JM; Laugier C Biol Cell; 1991; 72(1-2):181-6. PubMed ID: 1661631 [TBL] [Abstract][Full Text] [Related]
17. Relationship of hormone dependency to estrogen receptor and adenosine 3',5'-cyclic monophosphate-binding proteins in rat mammary tumors. Bodwin JS; Clair T; Cho-Chung YS J Natl Cancer Inst; 1980 Feb; 64(2):395-8. PubMed ID: 6928231 [TBL] [Abstract][Full Text] [Related]
18. Anticarcinogenic effect of N6,O2'-dibutyryl cyclic adenosine 3':5'-monophosphate on 7,12-dimethylbenz(a)anthracene mammary tumor induction in the rat and its relationship to cyclic adenosine 3':5'-monophosphate metabolism and protein kinase. Cho-Chung YS; Clair T; Shepheard C Cancer Res; 1983 Jun; 43(6):2736-40. PubMed ID: 6303567 [TBL] [Abstract][Full Text] [Related]
19. Increased activity of type I regulatory subunit of cyclic adenosine 3',5'-monophosphate-dependent protein kinase in estrogen-induced pituitary tumors. Piroli G; Pignataro O; De Nicola AF J Natl Cancer Inst; 1992 Oct; 84(20):1565-71. PubMed ID: 1328659 [TBL] [Abstract][Full Text] [Related]
20. Alterations in enzymes related to adenosine 3',5'-monophosphate during compensatory growth of rat lung. Nijjar MS; Thurlbeck WM Eur J Biochem; 1980 Apr; 105(2):403-7. PubMed ID: 6247152 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]